Elizabeth A Olek is SR VP, CLINICAL SCIENCE of Kronos Bio, Inc.. Currently has a direct ownership of 193,275 shares of KRON, which is worth approximately $222,266. The most recent transaction as insider was on Feb 21, 2024, when has been sold 7,368 shares (Common Stock) at a price of $1.05 per share, resulting in proceeds of $7,736. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 193K
0% 3M change
n/a 12M change
Total Value Held $222,266

Elizabeth A Olek Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2024
SELL
Open market or private sale
$7,736 $1.05 p/Share
7,368 Reduced 3.67%
193,275 Common Stock
EAO

Elizabeth A Olek

SR VP, CLINICAL SCIENCE
San Mateo, CA

Track Institutional and Insider Activities on KRON

Follow Kronos Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRON shares.

Notify only if

Insider Trading

Get notified when an Kronos Bio, Inc. insider buys or sells KRON shares.

Notify only if

News

Receive news related to Kronos Bio, Inc.

Track Activities on KRON